ArticleMultiple sclerosis journal - experimental, translational and clinical

Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program.

Marco Salvetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.